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Gottron’s Papules Exhibit Dermal Accumulation of
CD44 Variant 7 (CD44v7) and Its Binding Partner
Osteopontin: A Unique Molecular Signature
Jessica S. Kim1,2,3, Muhammad M. Bashir2,3 and Victoria P. Werth2,3
The accumulated mucin in non-Gottron’s dermatomyositis (DM) lesions is primarily chondroitin-4-sulfate (C4S),
which is immunomodulatory in vitro. Gottron’s papules are a particularly resistant manifestation of DM that
often persist after other lesions have resolved with therapy. We examined non-Gottron’s DM lesions and
Gottron’s papule skin biopsies for C4S, CD44 variant 7 (CD44v7), a chondroitin sulfate-binding isoform causally
implicated in autoimmunity, and osteopontin (OPN), a CD44v7 ligand implicated in chronic inflammation.
Gottron’s papule dermis contained more C4S and CD44v7 than non-Gottron’s lesions. Normal skin showed less
CD44v7 over joints relative to Gottron’s lesions. All DM dermis had increased OPN compared with healthy skin.
Mechanically stretching cultured fibroblasts for 6 hours induced CD44v7 mRNA and protein, whereas IFN-g
treatment induced OPN mRNA and protein. OPN alone did not induce CD44v7, but stretching dermal
fibroblasts in the presence of OPN increased human acute monocytic leukemia cell line (THP-1) monocyte
binding, which is blunted by anti-CD44v7 blocking antibody. C4S, CD44v7, and OPN are three molecules
uniquely present in Gottron’s papules that contribute to inflammation individually and in association with one
another. We propose that stretch-induced CD44v7 over joints, in concert with dysregulated OPN levels in the
skin of DM patients, increases local inflammatory cell recruitment and contributes to the pathogenesis and
resistance of Gottron’s papules.
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INTRODUCTION
Dermatomyositis (DM) is an autoimmune disorder with
characteristic skin findings, including Gottron’s papules over
the extensor surfaces of large and small joints, most fre-
quently of the hands (Callen, 2010). The pathogenesis of
these skin findings remains unexplained.
Histology of DM skin lesions includes upper dermal
deposition of mucin, which is strongest where it co-localizes
with the mononuclear infiltrate (Janis and Winkelmann,
1968). Recently, our group molecularly characterized the
accumulated mucin in non-Gottron’s DM lesions as primarily
chondroitin-4-sulfate (C4S; Kim and Werth, 2011). Published
reports indicate that C4S has immunomodulatory effects
in vitro, which may contribute to inflammation via monocyte
activation or counteract it by blocking the effects of tumor
necrosis factor-a and IL-1b (Rachmilewitz and Tykocinski,
1998; Fioravanti and Collodel, 2006; Xu et al., 2008).
In the current study, we focused on Gottron’s papules, a
particularly resistant manifestation of DM that often persists
after other lesions have resolved with therapy. Two reports
to date describe histologically similar findings in Gottron’s
papules as in other DM lesions (Hanno and Callen, 1985;
Mendese and Mahalingam, 2007), but these similarities
cannot explain the divergent clinical courses. Because C4S
has not previously been reported in Gottron’s papules, we
now hypothesized that this molecule and its associated
binding partners might differ between Gottron’s papules and
photodistributed non-Gottron’s DM skin lesions.
RESULTS
Gottron’s papules contain increased content of C4S and CD44
variant 7 (CD44v7) compared with other active DM lesions
or location-matched healthy controls
Immunohistochemical analysis of Gottron’s biopsies of DM
patients demonstrated a similar distribution of papillary
dermal C4S as in all other DM skin lesions, but with a
striking density exceeding that of samples from other loca-
tions. Compared with healthy control biopsies (Figure 1a),
samples taken from non-Gottron’s DM lesions (Figure 1b)
exhibited a mean 2.9-fold increased density of C4S.
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Compared with healthy control interphalangeal (IP) biopsies
(Figure 1c), samples from Gottron’s lesions (Figure 1d)
exhibited a 4.6-fold increased density of C4S (both Po0.001).
Gottron’s lesions had a mean 1.6-fold C4S density compared
with biopsies from other non-Gottron’s DM lesions (Po0.01).
C4S was not present in the epidermis of any samples.
We next investigated the Gottron’s biopsies for dermal
expression of proteins that interact with chondroitin sulfate
(CS). Many proteins covalently or non-covalently attach to
CS, but of these proteins only the variant 7 (v7) isoform of
CD44 has also been causally implicated in autoimmunity
(Wittig et al., 2000, 2002; Marhaba et al., 2003; Farkas et al.,
2005; Hoffmann et al., 2007). The v7 domain, as well as one
region within the ‘‘standard’’ CD44 (CD44s) that lacks any of
the variant domains, acts as a covalent attachment site for CS,
whereas CD44v6-7 has also been shown to non-covalently
bind CS (Sleeman et al., 1997; Keller et al., 2007). Thus, we
examined our samples for expression of CD44s and variant
isoforms CD44v3, v6, and v7 (Kim and Werth, 2011). Con-
sistent with previous reports, we observed strong epidermal
expression of CD44s, CD44v3, and CD44v6 in healthy
control skin, particularly within the basal layer and stratum
spinosum, but scant dermal matrix expression beyond
staining of infiltrating leukocytes (Leigh et al., 1996; Seiter
et al., 1996, 1998). Non-Gottron’s and Gottron’s DM lesions
exhibited qualitatively stronger CD44s and CD44v3 staining
within vessels compared with healthy controls; however,
dermal staining patterns of CD44s, CD44v3, and CD44v6 in
healthy controls, non-Gottron’s, and Gottron’s lesions did not
show significant differences (data not shown). We found no
detectable CD44v6 in any dermal sample, despite abundant
pericellular keratinocyte staining in the epidermis in the same
slides, which served as an internal positive control.
By contrast, Gottron’s biopsies demonstrated a mean
4.5-fold denser accumulation of CD44v7 within the papillary
dermal matrix compared with healthy control non-IP biopsies
(Po0.001), and a mean 2.5-fold CD44v7 density compared
with the dermis of non-Gottron’s lesions (Po0.01; Figure 2).
Non-Gottron’s lesions did not differ from controls, and this
differential expression was specific to CD44v7.
To study the effect of location versus disease in our patient
samples, we acquired biopsies from the skin overlying the
fourth proximal IP joint of five healthy volunteers with no
history of autoimmune disease. Immunohistochemistry of
healthy IP skin was compared with Gottron’s samples to
reveal a 4.5-fold greater density of C4S (Po0.001) and a
2.8-fold greater density of CD44v7 (Po0.01) in the IP dermis
of patients with disease. For within-person comparisons,
we also obtained a second biopsy from either the shoulder or
the arm of two healthy volunteers. C4S density was not
significantly different in the skin overlying the IP joint
compared with non-IP skin of either volunteer. CD44v7
density in IP skin, however, demonstrated a modest but
significant 1.6-fold (t-test P¼0.0149) and 1.4-fold (t-test
P¼0.0307) increase compared with that in non-IP skin in the
two volunteers, respectively.
DM dermis contains increased osteopontin (OPN) protein
OPN is a known binding ligand for CD44v7, and this specific
interaction has been implicated in chronic inflammation
(Denhardt et al., 2001). OPN is present in the spinous and
granular layers of normal epidermis, and around sweat
glands, hair follicles, and sebaceous glands of the dermis
(Chang et al., 2008). Our examination of healthy control skin
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Figure 1. Gottron’s papules (GP) exhibit unusually dense deposits of
chondroitin-4-sulfate (C4S) in the papillary dermis. Biopsies are stained with
an antibody against C4S. (a) Healthy control skin (HC, non-interphalangeal
(non-IP)). (b) Dermatomyositis (DM) lesions (DM, non-GP). (c) The proximal
IP of healthy volunteers (HC, IP). (d) GP. Representative photomicrographs
are shown, original magnification  5, bar¼100 mm. (e) Systematic
quantification of C4S staining intensity within the papillary dermal matrix.
Every data point is displayed; wide and short horizontal bars represent mean
and SEM, respectively. Po0.0001 by analysis of variance (***Po0.001;
**Po0.01). NS, not significant.
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revealed similar patterns (Figure 3a). However, compared
with location-matched healthy controls, biopsies taken from
non-Gottron’s (Figure 3b) and Gottron’s lesions (Figure 3c)
exhibited increased accumulation of OPN diffusely distrib-
uted throughout the dermis. Quantitative analysis of dermal
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Figure 2. Gottron’s papules (GP), but not non-Gottron’s dermatomyositis
(DM) lesions, exhibit abundant accumulation of CD44 variant 7 (CD44v7)
in the papillary dermis. Sequential sections taken from the same biopsies
shown in Figure 1 are stained with an antibody specific for CD44v7.
(a) Healthy control skin (HC, non-interphalangeal (non-IP)). (b) Non-Gottron’s
DM lesions (DM, non-GP). (c) The proximal IP of healthy volunteers (HC, IP).
(d) GP. Representative photomicrographs are shown, original magnification
5, bar¼ 100mm. (e) Systematic quantification of CD44v7 staining intensity
within the papillary dermal matrix. Every data point is displayed; wide and
short horizontal bars represent mean and SEM, respectively. P¼ 0.0003 by
analysis of variance (***Po0.001; **Po0.01). NS, not significant.
HC, non-IP DM, non-GP HC, IP GP
0.0
0.1
0.2
0.3 *
NS
NS
*
NS
**
St
ai
ni
ng
 in
te
ns
ity
 (o
ste
op
on
tin
)
Figure 3. Both Gottron’s papules (GP) and non-Gottron’s dermatomyositis
(DM) lesions exhibit abundant accumulation of osteopontin, a CD44
variant 7-binding partner, in the papillary dermis. Sequential sections
taken from the same biopsies shown in Figures 1 and 2 are stained with
an antibody specific for osteopontin. (a) Healthy control skin (HC,
non-interphalangeal (non-IP)). (b) Non-Gottron’s DM lesions (DM, non-GP).
(c) The proximal IP of healthy volunteers (HC, IP). (d) GP. Representative
photomicrographs are shown, original magnification  5, bar¼ 100 mm.
(e) Systematic quantification of osteopontin staining intensity within the
papillary dermal matrix. Every data point is displayed; wide and short
horizontal bars represent mean and SEM, respectively. P¼ 0.0036 by analysis
of variance (**Po0.01; *Po0.05). NS, not significant.
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OPN revealed a mean 3.3-fold greater density in non-
Gottron’s samples compared with healthy control samples
(Po0.01) and a 2.5-fold OPN density in Gottron’s samples
compared with healthy controls (Po0.05; Figure 3d). OPN in
Gottron’s lesions was not found to be significantly different
from that in non-Gottron’s DM lesional skin, nor did OPN in
healthy control IP skin differ from healthy control non-IP skin.
Mechanical stretching of dermal fibroblasts in vitro induces
CD44v7 mRNA expression
Because mechanical stretching has been reported to induce
expression of CD44v7 and v8 in porcine ocular trabecular
meshwork cells (Keller et al., 2007), we hypothesized that the
increased CD44v7 seen in the IP skin of DM patients and
healthy volunteers is induced by chronic stretching of the
skin over joints. Thus, we stretched primary dermal fibro-
blasts on cell culture membrane inserts and then determined
CD44v7 mRNA expression by quantitative real-time PCR
(reverse-transcriptase–PCR). We found that mechanical
stretching of dermal fibroblasts induced a significant 1.6-fold
increase in CD44v7 mRNA expression at 6 hours (Po0.01),
which returned to a baseline expression by 12 hours
(Figure 4a). CD44v7 protein in the supernatant of stretched
fibroblasts at 6 hours increased 3.3±1.3 times relative to
control fibroblasts (Po0.05; Figure 4b and c). OPN alone did
not induce CD44v7 mRNA (data not shown). These results
were reproducible in three repeat experiments. By contrast,
mechanical stretching did not have a significant effect on
fibroblastic OPN mRNA expression.
IFN-c induces OPN mRNA expression in cultured dermal
fibroblasts
IFN-g has been reported to stimulate OPN expression in
monocytes (Li et al., 2003), but this induction has not been
studied in dermal fibroblasts. Because IFN-g is present in the
skin of DM patients (Caproni et al., 2005; Wenzel et al.,
2005), and mutations in the IFN-g pathway have been
associated with DM (Chinoy et al., 2007), we hypothesized a
role for IFN-g in the dysregulation of OPN expression in the
skin. Treatment of human primary dermal fibroblasts with
IFN-g (10 ngml1) induced a 4.4-fold mean OPN mRNA
expression compared with untreated control cells in vitro
(Po0.001; Figure 5a). IFN-g (10 ngml1) induced an 8.1-fold
increase in OPN protein in fibroblast supernatant (Po0.001;
Figure 5b). OPN mRNA and protein in the fibroblast
supernatant were not induced by the pro-inflammatory
cytokines IL-1a or IFN-a, indicating specificity (Figure 5a
and b). Neither IFN-g nor OPN treatment had a significant
effect on fibroblast CD44v7 mRNA expression (data not
shown).
Mechanical stretching of dermal fibroblasts treated with OPN
increases human acute monocytic leukemia cell line (THP-1)
monocyte adhesion
On the basis of these findings, we hypothesized that the
increased CD44v7 in association with its ligand OPN could
have a crucial role in the localized inflammation of Gottron’s
papules. To study the functional effect of increased CD44v7
ligation with OPN on immune cell recruitment, we incubated
dermal fibroblast monolayers overnight, without or with
stretching, without or with recombinant human OPN (rOPN),
followed by rinsing. Fluorescently labeled THP-1 mono-
cytes were then cocultured with the prepared fibroblast
monolayers, followed by rinsing to remove non-adherent
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Figure 4. Mechanical stretching induces CD44 variant 7 (CD44v7) in
cultured human dermal fibroblasts. Confluent cultured human dermal
fibroblasts grown on flexible membranes were subjected to tonic mechanical
stretching. All cells were plated simultaneously and stretched for the final
6 or 12 hours of incubation, after which RNA was harvested simultaneously.
(a) CD44v7 mRNA levels were assayed by quantitative real-time reverse-
transcriptase–PCR, normalized to peptidylprolyl isomerase A (PPIA) mRNA
levels, and then expressed relative to unstretched controls. Every data point
from a representative experiment is displayed; wide and short horizontal bars
represent mean and SEM, respectively. P¼0.0017 by analysis of variance
(ANOVA; **Po0.01). (b) CD44v7 protein in the supernatant of stretched
fibroblasts at 6 hours was assayed by western blotting and expressed
relative to unstretched controls. (c) Mean CD44v7 protein detected in one
representative experiment; horizontal bar represents SEM. P¼ 0.0321 by
ANOVA (*Po0.05). GAPDH, glyceraldehyde-3-phosphate dehydrogenase;
NS, not significant.
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monocytes, and the adherent monocytes were visualized
with an inverted fluorescent microscope. We found that
overnight incubation of fibroblast monolayers in medium
supplemented with rOPN had no effect on THP-1 adhesion in
the absence of stretch (Figure 6). Stretching the fibroblasts in
the absence of rOPN supplementation resulted in an increase
in the number of adherent THP-1 cells by 1.8 times to that of
unstretched, no-rOPN controls (Figure 6; Po0.01). Stretching
fibroblasts overnight in medium supplemented with rOPN
resulted in an increase in THP-1 adhesion by 2.2 times to that
of stretched fibroblasts without rOPN (Po0.001) and by 2.3
times to that of unstretched, no-OPN controls (Po0.001).
To demonstrate the specific effect of fibroblast CD44v7 on
THP-1 adhesion, we incubated prepared fibroblast mono-
layers with anti-CD44v7 blocking antibody or isotype control
IgGk for 1 hour immediately before THP-1 coculture.
Stretched, rOPN-treated monolayers blocked with anti-
CD44v7 antibody demonstrated a 41% reduction in THP-1
adhesion compared with identically prepared fibroblast
monolayers incubated with control isotype IgGk (Figure 6;
Po0.001).
DISCUSSION
In the current study, we found a unique molecular signature
of Gottron’s papules that consists of a dense dermal
deposition of C4S, abundant amounts of a C4S-binding
molecule, CD44v7, which has been causally linked to
autoimmunity, and co-localized deposits of OPN, a cyto-
kine-like factor that cooperates with CD44v7 to recruit
inflammatory cells. By contrast, non-Gottron’s DM lesions
had far less C4S and exhibited levels of CD44v7 that were
indistinguishable from the low amounts in skin from healthy
controls. OPN was present in non-Gottron’s DM lesions, but
the ability of this molecule to recruit immune cells remains
unproven in the near absence of CD44v7, its major binding
partner. The combination of mechanical stretch to induce
CD44v7 over the extensor surfaces of joints with IFN-g,
a factor that induces OPN expression and occurs more
generally in the skin of DM (Caproni et al., 2005; Wenzel
et al., 2005), may explain the co-localization of these
molecules in Gottron’s papules.
The CD44v7 chondroitin sulfate proteoglycan is of parti-
cular interest in autoimmunity as a demonstrated mediator of
cell homing, adhesion, and survival. The soluble pattern of
CD44v7 seen in our samples is probably the result of CD44
shedding and sequestration through its association with the
cell-associated matrix; shed CD44 also competes with cell
surface CD44 for ligand binding, modulation, or disruption of
CD44-dependent cell–cell and cell–matrix adhesion (Cichy
and Pure, 2003). In a mouse model of experimental colitis,
anti-CD44v7 antibody treatment blocks T-cell extravasation
and recruitment to the intestinal mucosa, thus curing colitis
(Wittig et al., 2002; Farkas et al., 2005). Blockade of CD44v7
also induces apoptosis of mononuclear cells that had been
extracted from the inflamed mucosa of patients with Crohn’s
disease (Wittig et al., 2002).
The role of OPN in autoimmunity is an area of active
investigation. OPN gene polymorphisms associate with
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Figure 5. IFN-c, but not IFN-a or IL-1a, induces osteopontin (OPN) in
cultured dermal fibroblasts. Confluent cultured human dermal fibroblasts
were incubated for 6 hours in control medium or in medium supplemented
with IFNg (10 ngml1), IFNa (100Uml1), or IL-1a (20 ngml1), after which
RNA or conditioned media for ELISA was harvested; data from representative
experiments are displayed. (a) OPN mRNA levels were assayed by
quantitative real-time reverse-transcriptase–PCR, normalized to peptidylprolyl
isomerase A (PPIA) mRNA levels, and expressed relative to control; points
denote mean OPN/PPIA mRNA for each well (sampled in triplicate); wide and
short horizontal bars represent mean and SEM of triplicate conditions,
respectively. Po0.0001 by analysis of variance (ANOVA; ***Po0.001).
(b) OPN protein in control and conditioned media was quantified by
ELISA; mean OPN protein detected (ngml1) is indicated; horizontal bar
represents SEM of triplicate conditions. P¼ 0.0003 by ANOVA (***Po0.001).
NS, not significant.
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Figure 6. Mechanical stretching of fibroblasts, particularly in combination
with osteopontin (OPN) treatment, augments the adhesion of human acute
monocytic leukemia cell line (THP-1) monocytes, in a process dependent on
CD44 variant 7 (CD44v7). Confluent monolayers of cultured human dermal
fibroblasts grown on flexible membranes were incubated overnight without or
with OPN, without or with stretch, as indicated. Unbound OPN was rinsed
away, and then adherence of fluorescently labeled THP-1 monocytes onto
these monolayers was assessed. Wells were incubated for 1 hour following
treatment with anti-CD44v7 blocking antibody or isotype control Ig, and
then washed just before addition of the labeled monocytes. Representative
fluorescent micrographs of adherent monocytes (green dots) are shown.
(a) Control fibroblasts. (b) Mechanically stretched fibroblasts. (c) Mechanically
stretched fibroblasts pretreated with recombinant OPN (rOPN). (d) Counts of
adherent, fluorescent monocytes per high-power field (HPF; means±SEM,
n¼ 6), Po0.0001 by analysis of variance (***Po0.001; **Po0.01;
*Po0.05). NS, not significant.
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autoimmune diseases, including systemic lupus erythemato-
sus, rheumatoid arthritis, and multiple sclerosis, and plasma
OPN concentration is correlated with systemic lupus
erythematosus susceptibility, serum cytokine profiles, and
disease activity (Forton et al., 2002; Wong et al., 2005; Han
et al., 2008; Kariuki et al., 2009). A polymorphism for OPN in
a cohort of newly diagnosed juvenile DM patients was asso-
ciated with increased serum IFN-a level (Niewold et al., 2010).
Demonstrated immunological functioning of OPN inclu-
des polyclonal B cell and macrophage activation in auto-
immune murine models and activation-induced T-cell death
(Singh et al., 1990; Lampe et al., 1991; Weber and Cantor,
2001; Chiocchetti et al., 2004). In the skin, OPN secreted
by activated T cells is thought to enhance T helper type
1-mediated immunity through interaction with immune cells:
OPN enhances production of IFN-a in plasmacytoid dendritic
cells, has chemotactic properties for macrophages, dendritic
cells, and T cells, and OPN encountered by dendritic cells
in the dermal matrix activates and polarizes Langerhans
cells and myeloid-type dendritic cells toward a T helper
type 1 phenotype, directing them to draining lymph nodes
(Giachelli et al., 1998; O’Regan et al., 2000; Weiss et al.,
2001; Kawamura et al., 2005; Renkl et al., 2005). The
specific dose- and integrin-dependent binding of OPN to
CD44 is implicated with roles in adhesion, migration,
modulation of cytokine secretion, anti-apoptotic signaling,
and tumor invasion (Anborgh et al., 2010). For example,
OPN induces CD44-dependent chemotaxis and down-
modulates anti-inflammatory IL-10 secretion through inter-
actions with CD44, and is hypothesized as an activator of the
CD44 variant survival signal in lymphocytes by the extra-
cellular matrix of the gut mucosa (Weber et al., 1996; Katagiri
et al., 1999; Ashkar et al., 2000; Denhardt et al., 2001).
Intriguingly, CD44v7, a principal CD44 isoform sufficient
for OPN binding (Katagiri et al., 1999), is the isoform present
in our Gottron’s papules. We have previously shown CD44v7
expression in discoid lupus erythematosus skin (Kim and
Werth, 2011). However, OPN is not found in abundance
within discoid lupus erythematosus lesions, and accordingly
the OPN/CD44v7 complex is not seen.
C4S and CD44 are known to contribute to cellular
adhesion (Murai et al., 2004; Charbonneau et al., 2007).
Our THP-1 cell adhesion assay mimics the co-expression of
CD44v7 and OPN in active areas of active inflammation in
Gottron’s papules of DM, and its results demonstrate the
adhesive interactions regulated by stretch-induced CD44v7
on dermal fibroblasts complexed with OPN. Stretching of
dermal fibroblasts may induce upregulation of a variety of
molecules, but the inhibitory effect of anti-CD44v7 mono-
clonal antibody implicates a functional role specific to this
molecule in adhesion.
Thus, the present study identifies C4S, CD44v7, and OPN
as three molecules that contribute to inflammation individu-
ally and in association with one another and are uniquely
present together in Gottron’s papules. We propose that
stretch-induced expression of CD44v7 overlying joints, in
concert with dysregulated levels of OPN generally in the skin
of DM patients, increases local recruitment of leukocytes and
contributes to the pathogenesis and resistance of Gottron’s
papules. A greater understanding of these molecules and the
consequence of their accumulation in DM skin lesions may
ultimately provide new therapeutic targets.
MATERIALS AND METHODS
Skin specimen collection
Lesional skin biopsies from patients with DM (n¼ 10) were obtained
in the autoimmune skin disease clinic at Penn. Five biopsies were
taken from Gottron’s papules over the proximal IP or metacarpo-
phalangeal joints, and five unmatched biopsies were taken from
active lesions on the arm, shoulder, or chest. Healthy control skin
was provided by volunteers (n¼ 10) without a history of auto-
immune skin disease; five biopsies were from skin overlying the
proximal IP of the third digit, and five biopsies were from sun-
protected arm. Two volunteers provided both a proximal IP and arm
or shoulder sample. All biopsies were obtained with written,
informed patient consent and adherence to the Helsinki Guidelines
according to our approved protocol under the UPenn Institutional
Review Board. Biopsies were fixed in 10% neutral-buffered formalin
overnight, embedded in paraffin, and cut into 4-mm sections.
Immunostaining
Immunostaining for C4S was performed on human skin as described
previously (Chang et al., 2011a) by predigestion with chondroitinase
AC II (Sigma, St Louis, MO), followed by incubation with an anti-
deltaDi-4S monoclonal antibody that recognizes a terminal glu-
curonic acid residue adjacent to N-acetylgalactosamine-4-sulfate at
the nonreducing end of chondroitin sulfate chains in proteoglycans
produced after chondroitinase digestion of chondroitin sulfate chains
(clone 2-B-6, Seikagaku Biobusiness, Tokyo, Japan). We also
performed immunostaining using monoclonal antibodies against a
fusion protein of glutathione S-transferase with individual variant
domains (v3, v6, and v7) of human CD44 (AbD Serotec, Raleigh,
NC). Staining for CD44 v6 required heat-induced antigen retrieval,
whereby slides were incubated for 10minutes at 70 1C in Target
Retrieval Solution (Dako, Carpinteria, CA). OPN was detected using
a rabbit polyclonal antibody recognizing full-length, as well as
thrombin- and matrix metalloproteinase-cleaved, OPN (AbCam,
Cambridge, MA). Sections were then incubated with biotinylated
secondary antibody and streptavidin-horseradish peroxidase (Dako,
Carpinteria, CA), followed by Vector NovaRED substrate (Vector,
Burlingame, CA). Negative controls included mouse IgGk isotype
antibody (Sigma, St Louis, MO) and phosphate-buffered saline
instead of chondroitinase AC II enzyme digestion.
Systematic quantification of immunostaining
All high-power fields in three sections of each 3- to 5-mm skin
biopsy were examined at original magnification  10. Among all
fields examined, one high-power field appearing most representative
of all sections was selected from each biopsy to measure matrix
intensity, and this field was photographed at original magnification
 10. An intensity channel was applied to photograph files using
commercial software to isolate staining intensity (Image-Pro Plus
v5.0, Cybernetics, Bethesda, MD). One-hundred 5-mm circular
manual tags were selected by systematic uniform random sampling
of the area of interest (e.g., within the upper dermis for CD44v7;
Mayhew, 2008). The mean intensity of staining within the total area
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selected by the manual tags is reported as the representative staining
intensity value for each specimen.
Cell culture, mechanical stretch, and cytokine treatment
Normal adult, human fibroblasts were obtained from the American
Type Culture Collection (Rockville, MD). Mechanical stretching
experiments were conducted by seeding primary human dermal
fibroblasts onto membrane inserts (six-well format, 23.1-mm
diameter, 3.0-mm pore size, BD Falcon no. 353091, BD Biosciences,
Franklin Lakes, NJ) and culturing the cells to confluence (Keller
et al., 2007). Next, a smooth 5-mm glass bead was placed in the dish
beneath the center of the insert membrane, and constant weight was
applied to the lid of the insert to force the edge of the insert down
onto the bottom of the dish. This produced distortion of the
membrane, increasing its surface area and thereby mechanically
stretching the cells and their extracellular matrix. Stretching was
continued for 6 or 12 hours, and then each stretched membrane
insert was cut out, vortexed in RNAeasy lysate buffer, and RNA
purified, followed by quantitative PCR.
For cytokine stimulation, fibroblasts were plated in 100-mm-
diameter dishes and grown to confluence. Fibroblasts were treated
for 6 hours with 10ng IFN-gml1 (R&D Systems, Minneapolis, MN),
100U IFN-a per 2ml (PBL Interferon Source, Piscataway, NJ), or
20 ng recombinant human IL-1aml1, before lysis with the RNAeasy
mini kit lysate buffer and processing RNA (Qiagen, Valencia, CA).
Experiments were performed in triplicate and repeated three times
with reproducible results.
Quantitative real-time reverse-transcriptase–PCR
Quantification of specific mRNAs was performed as previously
described (Chang et al., 2011a). Total RNA was reverse transcribed
using the SuperScript First-Strand Synthesis System for reverse-
transcriptase–PCR (Invitrogen, Carlsbad, CA) with random hexamer
primers. Real-time PCR was performed using Taqman Gene Expres-
sion Assays for human OPN (Taqman Assay ID Hs00960942_m1;
Applied Biosystems, Foster City, CA) and peptidylprolyl isomerase A
(cyclophilin A), the housekeeping control (Taqman Assay ID
Hs99999904_m1; Applied Biosystems). Custom-made sequences
for detection of human CD44 exon 11 transcripts, which encode
exclusively the v7 motif, were 50-TGCAAGGAAGGACAACACCAA-
30 (sense primer) and 50-GGGTGTGAGATTGGGTTGAAGAAA t-30
(antisense primer). All reactions were performed in triplicate. The
DDCt method was used to analyze the differential gene expression in
cytokine-treated fibroblast cultures compared with controls, as
described previously (Chang et al., 2011b).
Western blot
Serum-free supernatant from control and stretched fibroblasts were
collected after 6 hours. The supernatants were centrifuged at
10,000g for 1minute. Equal amounts of protein (10 mg) were
separated on a 4–12% bis–tris gel (Invitrogen, Grand Island, NY),
transferred to a membrane (Millipore, Billerica, MA), and stained
with 1:2,000 dilution of mouse anti-human CD44v7 (AbD Serotec,
Oxford, UK). For loading control, the washed membrane was stained
with 0.1% Coomassie R-350 (GE Healthcare, Piscataway, NJ).
Western blot results were recorded by X-ray films (Kodak Scientific
Imaging, Truesense Imaging, Rochester, NY) and quantified by
ImageJ (Collins, 2007).
OPN protein determination by ELISA
Conditioned media from IFN-g, IL-1a, or IFN-a-treated cultured
fibroblasts were collected and concentrated 2-fold. The protein was
quantified by the CB-Protein-Assay-Kit (G-Biosciences, St Louis,
MO) and volume was adjusted to 100 uL, so that equal protein was
used for each sample. OPN protein was quantified by commercial
ELISA (R&D Systems, Minneapolis, MN).
Adhesion assay
Primary dermal fibroblasts were cultured to confluence on 23.1-mm
polyethylene terephthalate membrane inserts and then stretched, or
not, with 5-mm glass beads. Here, stretching lasted overnight and
was combined with treatment with 0 or 5mg of recombinant
OPNml1. Unbound OPN was rinsed with warmed phosphate-
buffered saline before the assay of monocyte adherence. Fibroblasts
were maintained in serum-free, phenol red–free DMEM for the
remainder of the assay. For inhibition studies, 25 mg of mouse anti-
human CD44v7 (AbD Serotec, Raleigh, NC) per milliliter or mouse
anti-human IgGk isotype antibody control (Sigma, St Louis, MO) per
milliliter was added to stretched monolayers after rinsing of unbound
OPN for 1 hour, and then washed. Living THP-1 monocytes
labeled with 5-chloromethylfluorescein diacetate (CellTracker
Green CMFDA, Invitrogen, Eugene, OR) were added (5 105/insert),
followed by a 30-min incubation at 37 1C. Unbound monocytes
were then removed by rising four times, and the number of
monocytes firmly bound to the fibroblast monolayers was counted
under fluorescent microscopy in six random high-power fields near
the centers of the stretched membranes, where the stretching was the
greatest. Experiments were repeated four times with reproducible
results.
Statistical analysis
Comparison of several groups simultaneously was performed by
initially using analysis of variance (GraphPad Prism v5.01). When
analysis of variance indicated differences among the groups,
pairwise comparisons between experimental groups were made
using the Student–Newman–Keuls q statistic and are indicated in
Figures 1–6. Unless otherwise indicated, summary statistics are
reported as mean±SEM.
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